Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...

Cancer cells have ways to hide from the immune system, but there are some unique features on these dangerous cells that ...

Scientists have unveiled two major CRISPR breakthroughs: a ThermoCas9 variant that can distinguish and cut tumor DNA while sparing healthy cells, and a retron-based editing system adapted from E. coli ...

Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...

Scientists have developed ThermoCas9, a CRISPR enzyme capable of distinguishing cancer cells from healthy ones by reading DNA methylation patterns, potentially reducing off-target edits. In lab tests, ...

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer. Researchers from Tel Aviv University (Israel), led by Razan Masarwy, have investigated utilizing CRISPR ...

Immunotherapeutic strategies have made huge strides in cancer treatment for many solid tumors over the past decade. But the promising results have failed to make a large change in the treatment of ...

CRISPR Therapeutics (NASDAQ: CRSP), a mid-cap biotech company, achieved a major milestone when it earned approval for the ...

Scientists design therapeutic approaches for cancer around mutations and variations that affect disease onset and progression. However, these determinants can differ across populations, and what ...

Zugo-cel, targeting CD19, is in an ongoing Phase 1 basket trial in autoimmune rheumatologic diseases. Preliminary clinical data from the Phase 1 study have been encouraging, and zugo-cel has been well ...